Next generation sequencing Market Growth, Statistics, By Application, Production, Revenue & Forecast To 2028

The global next generation sequencing market expected to reach US$ 25.85 billion by 2028 according to a new study by Polaris Market Research. The report “Next Generation Sequencing (NGS) Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research); By Technology; By Product; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global next-generation sequencing market is anticipated to grow owing to advancements in both technology and genetic data analysis through the use of bioinformatics and other computational tools. Market players are focusing on developing automated sequencers equipped with high speed and accuracy. Moreover, significant investments in start-ups causing intense competition, thereby reducing the cost of sequencing. This has also enabled increased adoption in emerging nations.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample

 

The global next-generation sequencing market is fragmented based on application, technology, product, end-use, and region. In terms of application, the market is segmented into drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others.

 

The technology market segment is further divided into the whole genome, targeted sequencing & re-sequencing, whole exome, RNA sequencing, chip sequencing, de novo sequencing, and methyl sequencing. The product market segment is further divided into instruments, reagents & consumables, and services. The end-use market segment is further divided into healthcare institutions, academics, biotech & pharma firms, and others.

  

Segment Highlights

• Infectious diseases segment is estimated to hold a major share in the global next generation sequencing market, owing to increasing usage of NGS in infectious diseases. Genetic screening segment is expected to expand at highest CAGR during the forecast.
• Based on technology, the target sequencing segment is projected to constitute almost half of the market in 2028. This can be attributed to the fact that concerned sequencing technique offers cost effective approach and increased market activities.
• North America region is dominating in the global next generation sequencing market, holding almost one third of the market share throughout forecast period. Recent spike in COVID-19 deaths in the U.S. and government funded genetic studies favoured the region’s growth.
• The players including QIAGEN, Oxford Nanopore Technologies, and Thermo Fisher Scientific Inc. together held a significant market share of global next generation sequencing industry in year 2020.

Get Special Discount On this Research Report : https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-discount-pricing

 

List of Key Players

• QIAGEN
• Thermo Fisher Scientific Inc.
• F Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies
• Genomatix GmbH
• PierianDx
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• BGI
• Bio-Rad Laboratories, Inc.
• Others

 

Polaris Market Research has segmented the next generation sequencing market report on the basis of application, technology, product, end-use and region

 Next Generation Sequencing, Application Outlook (Revenue – USD Million, 2016 – 2028)

• Drug Discovery/Personalized Medicine
• Genetic Screening
• Diagnostics/Infectious Diseases
• Agricultural & Animal Research
• Others

Next Generation Sequencing, Technology Outlook (Revenue – USD Million, 2016 – 2028)

• Whole Genome Sequencing
• Targeted Sequencing & Re-sequencing
• Whole Exome Sequencing
• RNA Sequencing
• Chip Sequencing
• De Novo Sequencing
• Methyl Sequencing

Next Generation Sequencing, Product Outlook (Revenue – USD Million, 2016 – 2028)

• Instruments
• Reagents & Consumables
• Services

Next Generation Sequencing, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

• Healthcare Institutions
• Academics
• Biotech & Pharma Firms
• Others

Next Generation Sequencing, Regional Outlook (Revenue – USD Million, 2016 – 2028)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

 

 

Next Generation Sequencing Market Future Opportunities, Production/Demand Analysis & Outlook To 2026

New York, NY 18 Nov 2019 : According to a new study published by Polaris Market Research, the global Next Generation Sequencing (NGS) market is anticipated to reach USD 16.6 billion by 2025. Next generation sequencing (NGS), is a DNA sequencing technology. The process of DNA sequencing, which decides the exact order of nucleotides inside a DNA molecule, is known as Next generation sequencing. Next generation sequencing is high throughput sequencing.  Using next generation sequencer, the process produces a million DNA molecules and RNA sequences by allowing rapid nucleotide sequencing. Roche 454 sequencing and Illumina sequencing are the modern technologies of next generation sequencing. In comparison to Sanger’s sequencing method, the next generation sequencing is much cost-effective technique that provides better outcomes for DNA sequencing. An entire human genome can be sequenced in a single day using next generation sequencing, however, the Sanger sequencing technology, used to decode the human genome, required over a decade to bring the final summary. 

By providing high flexibility, speed, throughput, and reduced sequencing cost, the introduction of next generation sequencing technologies has brought significant changes in sequencing technologies. In the single sequencing run, the next generation sequencing has ability to generate of nucleotide sequence data. The applications of next generation sequencing are in the field of cancer research, genetic disease research, personalized medicines, biological drug discovery, newborn sequencing metgenomics, and agriculture research etc. Moreover, non-coding RNA expression profiling, identification of binding sites on transcriptional factor, and re- sequencing of targets are some more applications of next generation sequencing.

 Download sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample

The adoption of next generation sequencing is mounting for diagnosis of inherited genetic disorders, cancer, HLA typing and identification of infectious diseases as it allows scanning of targeted genome in very small time, and this is expected to propel the growth of global next generation sequencing market over the forecast period.

The global market for next generation sequencing is segmented by application, technology, products, end user, and region. By application, the global next generation sequencing market is categorized as, drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others. The drug discovery/personalized medicine segment is estimated to account major share in global next generation sequencing market by application in 2017. The increasing demand of next generation sequencing base test for infectious diseases and cancer, and rising focus on developing and providing next generation sequencing- based diagnostic tests are the major factors contributing towards the high market share of the segment in the global market. Moreover, the growing research and development activities globally are significantly contributing towards the growth of market.

By Technology, the global next generation sequencing market is further sub segmented into Whole Genome Sequencing,    Targeted Re-Sequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. By technology, the targeted sequencing & Re-sequencing segment accounted major share in global next generation sequencing market. The targeted sequencing reduces the sequencing cost, and it is target specified and also requires smaller dataset. Moreover, increasing demand target specific genomic studies s expected to propel the growth of segment in the global next generation sequencing market.

 Get Exclusive Discount on This Report @  https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-discount-pricing

By product, the global next generation sequencing market is further categorized into instruments, reagents & consumables, and services.  By consumables, the global next generation sequencing market is further segmented into sample preparation consumables, and other consumables. The sample preparation sample includes quality control consumables, library preparation, DNA fragmentation, end repair, A-tailing, and size selection etc. On the basis of services, the global next generation market is segmented into data management services, and sequencing services. The sequencing services segment includes, Targeted Re-Sequencing, RNA Sequencing Chip-Seq, Methyl-Seq, De Novo Sequencing etc. where, the data management services includes, NGS storage, management, NGS data analysis software & workbenches, and NGS data analysis services.

 On the basis of end user, the global next generation sequencing market is further segmented into healthcare institutions, pharmaceutical & biotechnology companies,     research and academic centers, and others.  By end user, the research and academics segment accounted major share in global next generation sequencing market. High application of next generation sequencing tools in research is the one of the key factors contributing towards the high market share of the segment. The hospitals and clinics segment is expected to register high CAGR over the forecast period owing to increasing collaboration between hospitals and biotech and pharmaceutical companies to develop advanced test kits for diagnosis of diseases.

 Any Special Requirement Speak To our Expert @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/speak-to-analyst

Some of the key players operating in global next generation sequencing market are Thermo Fisher Scientific Inc., Illumina, Inc., Roche Holding AG,  QIAGEN N. V., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., GATC Biotech AG,  Perkin Elmer, Inc., Agilent Technologies, Inc., Macrogen, Inc. , and Eurofins Scientific among others.

About Polaris Market Research

We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us

Polaris Market Research

Phone: 1-646-568-9980

Email: sales@polarismarketresearch.com

Web: www.polarismarketresearch.com